Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding

International Journal of Obesity

Volumn 27, Issue 3, 2003, Pages 355-361

  Hanusch Enserer, U ^a   Cauza, E ^a   Spak, M ^a   Dunky, A ^a   Rosen, H R ^b   Wolf, H ^c   Prager, R ^d   Eibl, M M ^c,e  

^a Wilhelminenspital ^*  (Austria)

^b Wiener Krankenanstaltenverbund   (Austria)

^c Immunology Outpatient Clinic   (Austria)

^d GENERAL HOSPITAL LINZ   (Austria)

^e Immunology Outpatient Clinic   (Austria)

Author keywords

Acute phase proteins; Adjustable gastric banding; Inflammatory markers; Lymphocyte subsets; Weight loss

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN; OROSOMUCOID;

ADULT; ARTICLE; BODY MASS; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTRIC BANDING; HUMAN; LEUKOCYTE; LYMPHOCYTE SUBPOPULATION; MALNUTRITION; OBESITY; PRIORITY JOURNAL; WEIGHT REDUCTION;

ACUTE-PHASE PROTEINS; ACUTE-PHASE REACTION; ADULT; FEMALE; FOLLOW-UP STUDIES; GASTROPLASTY; HUMANS; IMMUNOGLOBULINS; LEUKOCYTE COUNT; LYMPHOCYTE SUBSETS; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE PERIOD; WEIGHT LOSS;

EID: 0037352817     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802240     Document Type: Article

References (44)

1. Burton BT, Foster WR. Health implications of obesity: an NIH consensus development conference. J Am Diet Assoc 1985; 11: 7-1121.
2. Seidell JC. Prevalence of obesity in Europe. Bibl Nutr Diet 1989; 44: 1-7.
3. Durazo-Arvizu RA, Goldbourt U, McGee DL. Body-mass index and mortality. N Engl J Med 2000; 342: 287-289.
4. Jousilathi P, Tuomiletho J, Vartiainen E, Pekkanen J, Puska P. Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland. Circulation 1996; 93: 1372-1379.
5. Ridker PM. Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view. Blood Coagul Fibrinolysis 1999; 10(Suppl 1): S9-S12.
6. Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 1999; 22: 1971-1977.
7. Schmidt MI, Duncan BB, Sharett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuia MI, Tracy RP, Heiss G. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities Study): a cohort study. Lancet 1999; 353: 1649-1652.
8. McMillan DE. Increased levels of acute-phase serum proteins in diabetes. Metabolism 1989; 38: 1042-1046.
9. Juhan-Vague I, Thompson SG, Jespersen J. Involvement of the hemostatic system in the insulin resistance syndrome: a study of 1500 patients with angina pectoris: the ECAT Angina pectoris Study Group. Atherioscler Thromb 1993; 13: 1865-1873.
10. Haffner SM, Mykkanen L, Festa A, Burke JP, Stern MP. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation 2000; 101: 975-980.
11. Pickup JC, Mattock MB, Chusney GD, Butt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40: 1286-1292.
12. Yudkin JS, Kumari M, Humphries SE, Hohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000; 148: 209-214.
13. Ferri C, Desideri G, Valenti M, Bellini C, Pasin M, Santucci A, DeMattia G. Early upregulation of endothelial adhesion molecules in obese hypertensive men. Hypertension 1999; 34(Pt 1): 568-573.
14. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996; 312: 1061-1065.
15. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and instable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997; 349: 462-466.
16. Kuller LH, Tracy RP, Shaten J, Meilahn EN, for the MRFIT group. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996; 144: 537-547.
17. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men, N Engl J Med 1997; 336: 973-979.
18. Freedman DS, Joesoef MR, Barboriak JJ, Stallone DD, Byers T. Correlates of leukocyte counts in men. Ann Epidemiol 1996; 6: 74-82.
19. Brownell KD, Grennwood MRC, Stellar E, Shrager EE. The effect of repeated cycles of weight loss and regain in rats. Physiol Behav 1986; 38: 459-464.
20. Yang H, Peterson GM, Roth MP, Schoenfield LJ, Marks JW. Risk factors for gallstones during rapid weight loss. Digestive Dis Sci 1992; 37: 912-918.
21. National Task Force on the Prevention and Treatment of Obesity. Weight Cycling. J Am Med Assoc 1994; 272: 1196-1202.
22. Kuzmak LI. A review of seven years' experience with silicone gastric banding. Obes Surg 1991; 1: 403-408.
23. Miller K, Hell E. Laparoscopic adjustable gastric banding: a prospective 4-year follow-up study. Obes Surg 1999; 9: 183-187.
24. Luyckx FH, Sheen AJ, Desaive C, Dewe W, Gielen JE, Levebvre PJ. Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity. Diabetes Metab 1998 Sep; 24(4): 356-361.
25. Favretti F, Cadiere GB, Segato G, Bruyns G, De Marchi F, Himpens J, Foletto M, Lise M. Laparoscopic adjustable silicone gastric banding: technique and results. Obes Surg 1995; 5: 364-337.
26. Field CJ, Gougeon R, Marliss EB. Changes in circulating leukocytes and mitogen responses during very-low-energy all-protein reducing diets. Am J Clin Nutr 1991; 54: 123-129.
27. Mc Murray RWQ, Bradsher RW, Steele RW, Pilkington NS. Effect of a prolonged modified fasting in obese persons on in vitro markers of immunity: lymphocyte function and serum effects on normal neutrophils. Am J Med Sci 1990; 299: 379-385.
28. Tanaka S, Inoue S, Isoda F, Waseda M, Ishihara M, Yamakawa T, Sugiyama A, Takamura Y, Okuda K. Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord 1993; 17: 631-636.
29. Nieman DC, Nehlsen-Cannarella SL, Henson DA, Butterworth DE, Fagoaga OR, Warren BJ, Rainwater MK. Immune response to obesity and moderate weight loss. Int J Obes Relat Metab Disord 1996; 20: 353-360.
30. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 1992; 55(Suppl): 615S-619S.
31. Busetto L, Valente P, Pisent C, Segato G, de Marchi F, Favretti F, Lise M, Enzi G. Eating pattern in the first year following adjustable silicone gastric banding (ASGB) for morbid obesity. Int J Obes Relat Metab Disord 1996; 20: 539-546.
32. Pepys MB. The acute phase response and c-reactive protein. In: Weatherall DJ, Ledingham JGG, Warrell DA (eds). Oxford textbook of medicine. Oxford University Press: New York, 1996.
33. Stallone DD. The influence of obesity and its treatment on the immune system. Nutr Rev 1994; 52: 37-50.
34. Chandra RK, Kutty KM. Immunocompetence in obesity. Acta Paediatr Scand 1980; 69: 25-30.
35. Maki PA, Newberne PM. Dietary lipids and immune function. J Nutr 1992; 122: 610-614.
36. Good RA, Lorenz E. Nutrition and cellular immunity. Int J Immunopharmacol 1992; 14: 361-366.
37. Scanga CB, Verde TJ, Paolone AM, Andersen RE, Wadden TA. Effects of weight loss and exercise training on natural killer cell activity in obese women. Med Sci Sports Exerc 1998; 30: 1666-1671.
38. Cason J, Ainley CC, Wolstencroft RA, Norton KRW, Thompson RPH. Cell-mediated immunity in anorexia nervosa. Clin Exp Immunol 1986; 64: 370-375.
39. Casper RC, Kirschner B, Sandstead HH, Jacob RA, Daus JM. An evaluation of trace minerals, vitamins and taste function in anorexia nervosa. Am J Clin Nutr 1980; 33: 1801-1808.
40. Pertschuk MJ, Crosby LO, Barot L, Mullen JL. Immunocompetence in anorexia nervosa. Am J Clin Nutr 1982; 35: 968-972.
41. Amstrong-Esther CA, Lacey JH, Crisp AH, Bryant TN. An investigation of the immune response in patients suffering from anorexia nervosa. Postgrad Med J 1978; 54: 395-400.
42. Fink S, Eckert E, Mitchell J, Crosby R, Pomeroy C. T-lymphocyte subsets in patients with abnormal body weight: longitudinal studies in anorexia and obesity. Int J Eat Disord 1996; 20: 295-305.
43. Mili F, Flanders WD, Boring JR, Annest JL, Destefano F. The associations of race, cigarette smoking and smoking cessation to measures of the immune system in middle-aged men. Clin Immunol Immunopathol 1991; 59: 187-200.
44. Stallone DD, Stunkard AJ, Zweiman B, Wadden TA, Foster GD. Delayed-type hypersensitivity response in obese women following weight reduction. Clin Diagn Lab Immunol 1994; 2: 202-205.